Clinical Trials Directory

Trials / Completed

CompletedNCT00328393

Effect of Pioglitazone on Ambulatory Blood Pressure

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
2 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
Male
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The anti-diabetic pioglitazone has been found to reduce casual blood pressure. To date, no data are available looking at this effect in detail. Especially, ambulatory blood pressure has not yet been utilized to confirm the hypothesis that pioglitazone has blood pressure lowering effects.

Conditions

Interventions

TypeNameDescription
DRUGPioglitazone45 mg 8 weeks
DRUGPlaceboPlacebo

Timeline

Start date
2007-03-01
Primary completion
2007-03-01
Completion
2011-01-01
First posted
2006-05-19
Last updated
2012-07-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00328393. Inclusion in this directory is not an endorsement.

Effect of Pioglitazone on Ambulatory Blood Pressure (NCT00328393) · Clinical Trials Directory